Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1991-10-24
|
pubmed:abstractText |
Hemodynamics and myocardial metabolism at rest and during exercise were investigated in 21 patients with heart failure. The patients were evaluated before and after long-term treatment (14 +/- 7 months) with the beta-adrenergic blocking agent metoprolol. Clinical improvement with increased functional capacity occurred during treatment. Maximal work load increased by 25% (104 to 130 W; p less than 0.001). Hemodynamic data showed an increased cardiac index (3.8 to 4.6 liters/min per m2; p less than 0.02) during exercise. Pulmonary capillary wedge pressure decreased at rest (20 to 13 mm Hg; p less than 0.01) and during exercise (32 to 28 mm Hg; p = NS). Stroke volume index (30 to 39 g.m/m2; p less than 0.006) and stroke work index (28 to 46 g.m/m2; p less than 0.006) increased during exercise and long-term metoprolol treatment. The arterial norepinephrine concentration decreased at rest (3.72 to 2.19 nmol/liter; p less than 0.02) but not during exercise (13.2 to 11.1 nmol/liter; p = NS). The arterial-coronary sinus norepinephrine difference suggested a decrease in myocardial spillover during metoprolol treatment (-0.28 to -0.13 nmol/liter; p = NS at rest and -1.13 to -0.27 nmol/liter; p less than 0.05 during exercise). Coronary sinus blood flow was unchanged during treatment. Four patients produced myocardial lactate before the study, but none produced lactate after beta-blockade (p less than 0.05). There was no obvious improvement in a subgroup of patients with ischemic cardiomyopathy. In summary, there were signs of increased myocardial work load without higher metabolic costs after treatment with metoprolol.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0735-1097
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1059-66
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1680132-Adrenergic beta-Antagonists,
pubmed-meshheading:1680132-Cardiomyopathy, Dilated,
pubmed-meshheading:1680132-Energy Metabolism,
pubmed-meshheading:1680132-Epinephrine,
pubmed-meshheading:1680132-Exercise,
pubmed-meshheading:1680132-Female,
pubmed-meshheading:1680132-Heart Failure,
pubmed-meshheading:1680132-Hemodynamics,
pubmed-meshheading:1680132-Humans,
pubmed-meshheading:1680132-Male,
pubmed-meshheading:1680132-Metoprolol,
pubmed-meshheading:1680132-Middle Aged,
pubmed-meshheading:1680132-Myocardium,
pubmed-meshheading:1680132-Norepinephrine,
pubmed-meshheading:1680132-Time Factors
|
pubmed:year |
1991
|
pubmed:articleTitle |
Exercise hemodynamics and myocardial metabolism during long-term beta-adrenergic blockade in severe heart failure.
|
pubmed:affiliation |
Wallenberg Laboratory of Cardiovascular Research, Sahlgren's University Hospital, Göteborg, Sweden.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|